The Effect of Diabetes Duration on the Response to Liraglutide and Glimepiride in Type 2 Diabetes

被引：0
|
作者：
Gabber, Alan
Matthews, David
Holst, Jens
Zinman, Bernard
Jensen, Klaus
Falahati, Ali
Vora, Jiten
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A197 / A197
页数：1
相关论文
共 50 条
  • [11] Liraglutide (Victoza) for Type 2 Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1335): : 25 - 27
  • [12] Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone
    Sean D Sullivan
    Rafael Alfonso-Cristancho
    Chris Conner
    Mette Hammer
    Lawrence Blonde
    Cardiovascular Diabetology, 8
  • [13] LONG-TERM OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES RECEIVING GLIMEPIRIDE COMBINED WITH LIRAGLUTIDE OR ROSIGLITAZONE
    Alfonso, R.
    Sullivan, S. D.
    Conner, C.
    Hammer, M.
    Blonde, L.
    VALUE IN HEALTH, 2009, 12 (03) : A102 - A102
  • [14] Effect of liraglutide on expression of inflammatory genes in type 2 diabetes
    Emilie H. Zobel
    Rasmus S. Ripa
    Bernt J. von Scholten
    Viktor Rotbain Curovic
    Andreas Kjaer
    Tine W. Hansen
    Peter Rossing
    Joachim Størling
    Scientific Reports, 11
  • [15] Effect of Liraglutide on Cardiovascular Markers in Type 2 Diabetes Mellitus
    Ren, Wei
    Guo, Jianjin
    Liu, Jie
    Xi, Guangxia
    DIABETES, 2015, 64 : A339 - A339
  • [16] Effect of liraglutide on expression of inflammatory genes in type 2 diabetes
    Zobel, Emilie H.
    Ripa, Rasmus S.
    von Scholten, Bernt J.
    Curovic, Viktor Rotbain
    Kjaer, Andreas
    Hansen, Tine W.
    Rossing, Peter
    Storling, Joachim
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [17] The effect of liraglutide on endothelial function in patients with type 2 diabetes
    Nandy, Debashis
    Johnson, Christopher
    Basu, Rita
    Joyner, Michael
    Brett, Jason
    Svendsen, Claus Bo
    Basu, Ananda
    DIABETES & VASCULAR DISEASE RESEARCH, 2014, 11 (06): : 419 - 430
  • [18] Effect of glimepiride on serum adiponectin level in subjects with type 2 diabetes
    Nagasaka, S
    Taniguchi, A
    Aiso, Y
    Yatagai, T
    Nakamura, T
    Nakai, Y
    Fukushima, M
    Kuroe, A
    Ishibashi, S
    DIABETES CARE, 2003, 26 (07) : 2215 - 2216
  • [19] Insulin treatment and longer diabetes duration both predict poorer glycaemic response to liraglutide treatment in type 2 diabetes: the Association of British Clinical Diabetologists Nationwide Liraglutide Audit
    Thong, Ken Y.
    Mcgowan, Barbara M.
    Htay, Thein
    Pernet, Andrew
    Kelly, Chris
    Rajeswaran, Chinnadorai
    Howell, Jill
    Duncan, Catriona
    Inkster, Berit
    Buchanan, Linda
    Kassim, Saiful
    Nayer, Rahul
    Barwell, Nicholas D.
    Walton, Christopher
    Ryder, Robert E. J.
    BRITISH JOURNAL OF DIABETES AND VASCULAR DISEASE, 2015, 15 (04): : 169 - +
  • [20] Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US
    Lee, W. C.
    Conner, C.
    Hammer, M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (05) : 897 - 906
12345